Floatz logo

Therapeutic Asset Ratings

130 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Fluzoparib
HER2 positive breast carcinoma
Fudan UniversityP2CCC (48)
Gsk 5733584
HER2 positive breast carcinoma
QuantumLeap Healthcare CollaborativeP2CCC (48)
Her-2 Pulsed Dc1
HER2 positive breast carcinoma
H. Lee Moffitt Cancer Center and Research InstituteP2CCC (48)
Hrs-4508
HER2 positive breast carcinoma
Fudan UniversityP2CCC (48)
Hrs-6209
HER2 positive breast carcinoma
Fudan UniversityP2CCC (48)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
HER2 positive breast carcinoma
QuantumLeap Healthcare CollaborativeP2CCC (48)
Inavolisib
HER2 positive breast carcinoma
GBG Forschungs GmbHP2CCC (48)
Ivonescimab
HER2 positive breast carcinoma
Fudan UniversityP2CCC (48)
js207
HER2 positive breast carcinoma
Fudan UniversityP2CCC (48)
Lasofoxifene
HER2 positive breast carcinoma
QuantumLeap Healthcare CollaborativeP2CCC (48)
LEUPROLIDE
HER2 positive breast carcinoma
Fudan UniversityP2CCC (48)
Margetuximab
HER2 positive breast carcinoma
MedSIRP2CCC (48)
Metformin
HER2 positive breast carcinoma
Qamar KhanP2CCC (48)
Mitoxantrone
HER2 positive breast carcinoma
Fudan UniversityP2CCC (48)
N-DESMETHYL-4-HYDROXYTAMOXIFEN
HER2 positive breast carcinoma
QuantumLeap Healthcare CollaborativeP2CCC (48)
NEBIVOLOL
HER2 positive breast carcinoma
Ain Shams UniversityP2CCC (48)
Parstuzumab
HER2 positive breast carcinoma
Henan Cancer HospitalP2CCC (48)
Pexidartinib
HER2 positive breast carcinoma
QuantumLeap Healthcare CollaborativeP2CCC (48)
Rilvegostomig
HER2 positive breast carcinoma
QuantumLeap Healthcare CollaborativeP2CCC (48)
Rivoceranib
HER2 positive breast carcinoma
Fudan UniversityP2CCC (48)
Sarilumab
HER2 positive breast carcinoma
QuantumLeap Healthcare CollaborativeP2CCC (48)
Shr-4602
HER2 positive breast carcinoma
Fudan UniversityP2CCC (48)
Shr-A1921
HER2 positive breast carcinoma
Fudan UniversityP2CCC (48)
Tislelizumab
HER2 positive breast carcinoma
Tianjin Medical University Cancer Institute and HospitalP2CCC (48)
tqb2868
HER2 positive breast carcinoma
Fudan UniversityP2CCC (48)
Showing 76 to 100 of 130 assets
PreviousPage 4 of 6Next